ArticleInternational journal of nanomedicine2025
ROS/pH Dual-Responsive Hydrogel Dressings Loaded with Amphiphilic Structured Nano Micelles for the Repair of Infected Wounds.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- pH-responsive injectable hydrogel dressing integrating antibacteria, antioxidation, anti-inflammation, and angiogenesis for infected wound healing.International journal of pharmaceutics: X · 2026Article
- A Scallop Active Peptide-Incorporated Carboxymethyl Chitosan/Oxidized Sodium Alginate Hydrogel for Accelerating Skin Wound Healing and Tissue Regeneration.Gels (Basel, Switzerland) · 2026Article
- Cellulose-Based Hydrogels for Chronic Wound Healing: Bridging Biomaterial Design and Clinical Unmet Needs.Gels (Basel, Switzerland) · 2026Review
- Hydrogel-Based Platforms for Wound Care: Integrated Strategies for Antimicrobial Delivery and Biofilm Management.Gels (Basel, Switzerland) · 2026Review
- Smart Antibiofilm Platforms Based on Synthetic Antimicrobial Peptides-Engineered Hydrogels.Polymers · 2026Review
- How Transformative Are ROS Responsive Hydrogel Nanoformulations to Treat Refractory Infected Wounds.International journal of nanomedicine · 2026Review
- A Glutathione-Responsive Prodrug Nanosystem for Colorectal Cancer: Synergistic Co-Delivery of Paclitaxel and Curcumin to Combat Multidrug Resistance and Reinvent the Immunosuppressive Microenvironment.Biomaterials research · 2026Article
- Stimuli-responsive hydrogels for radiation-induced skin injury: from passive barriers to autonomous drug delivery systems.Regenerative biomaterials · 2026Review
- Inflammation-Responsive Hydrogels in Perioperative Pain and Wound Management: Design Strategies and Emerging Potential.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bacterial infections in wounds have emerged as an increasingly significant healthcare concern. The toxins secreted by bacteria cause persistent inflammation and excessive oxidative stress, resulting in serious tissue damage and ultimately delay wound healing. Methods: Herein, a ROS/pH dual-responsive hydrogel dressing loaded with amphiphilic structured nano micelles was developed for efficiently promoting infected wound healing. First, chitosan-grafted α-lipoic acid (CSLA) and curcumin (Cur) formed stable amphiphilic nano micelles (CSLA@Cur) through ultrasonic self-assembly. Subsequently, CSLA@Cur was incorporated into a hydrogel formed from 4-carboxyphenylboronic acid-modified gelatin methacrylate (GelMA-CPBA) and oxidized chondroitin sulfate (OCS) via Schiff base formation, boronate ester bonding, and free radical polymerization to obtain GC/OCS-CL@Cur hydrogel dressing. The mechanical properties, antimicrobial, antioxidant, and ROS/pH responsiveness of GC/OCS-CL@Cur were evaluated. Cellular assays were performed to investigate the biocompatibility of GC/OCS-CL@Cur and its role in promoting angiogenesis, scavenging intracellular ROS and regulating macrophage polarization. A full-thickness skin defect rat model with bacterial infection was established to investigate the ability of GC/OCS-CL@Cur to enhance wound repair in vivo. Results: The unique cross-linked structure of GC/OCS-CL@Cur significantly improves the mechanical properties of hydrogels. Importantly, GC/OCS-CL@Cur exhibited sensitive ROS/pH dual responsiveness, which enabled the controlled release of CSLA@Cur and efficient delivery of Cur. Moreover, GC/OCS-CL@Cur possessed excellent antimicrobial activity and efficient ROS scavenging ability. In vitro cellular assays demonstrated that GC/OCS-CL@Cur could effectively scavenge intracellular ROS (up to 90% scavenging ratio), promote macrophage polarization to M2 phenotype, and enhance angiogenesis. In vivo experiments showed that GC/OCS-CL@Cur significantly regulated the expression level of inflammatory cytokines, and healed more than 95% of wounds in 14 days, showing excellent wound healing ability. Conclusion: These results demonstrate the successful development of a dual-responsive (ROS/pH) hydrogel dressing with integrated antibacterial, antioxidant, and anti-inflammatory properties, showcasing significant potential for treating infected wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.